Top Blood Viscometer Companies Advancing Precision Diagnostics and Healthcare Research

With the advent of Industry 4.0, the medical and pharmaceutical sectors have embarked on a new trail of sample measurement, resulting in the debut of tech-driven blood viscometers. Technologies such as AI (Artificial Intelligence), big data analysis, and IoT (Internet of Things) have enabled the development of high precision instruments for viscosity control and measurement. According to a study published in the National Institutes of Health’s National Library of Medicine in December 2024, microfluidic viscometers based on a meticulously designed microarray helped achieve a 95% accuracy in capturing the non-Newtonian behavior of blood and showed excellent reproducibility compared to conventionally-used rheometers and viscometers. The study has been addressed as a value addition to the methods for evaluating stroke risks, given the high level of precision.

The launch of such initiatives is likely to pave the way to the development of innovative equipment for viscosity measurement in the healthcare sector. The equipment is also finding its way in the field of drug formulation, where it is used for ensuring drug stability and quality. Medical diagnostics is another significant area where viscometers are used for the identification of several issues such as clotting disorders, dehydration, cardiovascular diseases, and others.

What are Blood Viscometers? Who are the Top Participants in this Sector?

Used for measuring the viscosity and thickness of plasma or blood, blood viscometers are increasingly being deployed in the diagnosis and treatment of several disorders. The products are used across research institutes for finding potential therapeutic solutions for numerous health conditions. A study by Fortune Business Insights estimates the global market for blood viscometer to hit USD 2.67 billion by 2034 from a value of USD 1.77 billion in 2026, soaring at a CAGR of 5.2% over 2026 to 2034. In line with the emerging avenues, top 10 blood viscometers companies are looking to augment their market share by joining forces with research institutions. They are also emphasizing the development of innovative products and footprint expansion to achieve their business goals.

An account of the 10 leading industry participants and their pivotal steps for consolidating industry standing has been furnished below:

1. Benson Viscometers – Clinical Viscometers

With headquarters located in the U.K., Benson Viscometers develops viscosity testing solutions that can be used to diagnose and monitor various conditions, including diabetes and cardiovascular disorders. The company places an emphasis on expansion initiatives and has augmented its footprint to cover the U.K., the U.S., and Europe. Following initial talks at MEDICA 2025 held in November 2025, the blood viscometer company struck collaborations with Sanollo and MedBridge. Under the same, Sanollo would support its global sales initiatives and MedBridge North America would support sales across Canada and the U.S.

2. RheoSense, Inc.

RheoSense, based in the U.S., has an extensive viscometer lineup that functions based on its VROC® technology. Some of the key offerings on its portfolio are VROC® initium 1++ and m-VROC® II. The company is committed to developing new products that help meet the requirements of its clientele base. This spirit can be seen in its February 2025 move, when it launched the microVISC PRO. This high-performance viscometer has been equipped for accurate measurements by deploying 100 µL of samples and features a built-in temperature control system.

3. proRheo GmbH

Focused on innovation, Germany-based proRheo is one of the top 10 blood viscometer companies. The company serves an extensive clientele base that spans 36 countries. Rheomat R190 and Rheomat R140 are some of the major laboratory viscometer offerings.

4. A&D Company, Limited

Founded in 1977, A&D Company is centered on developing weighing and measurement solutions, with an extensive portfolio of viscometers. The Japan-based blood viscometer company is dedicated to cultivating new markets to ensure the expansion of its footprint.

5. Inc.

U.S.-based AMETEK produces viscometers via AMETEK Brookfield, which is one of the major players in texture and viscosity analysis. The laboratory portfolio of the company comprises DVNext Rheometer, DVPlus Viscometer, and DV2Plus Viscometer, among others. In May 2025, AMETEK Brookfield struck a distribution agreement with DKSH Business Unit Technology. The move would provide AMETEK continued access to the latter’s extensive distribution network.

6. TA Instruments

In 1990, TA Instruments became a stand-alone business entity after separation from the DuPont Company. This U.S.-based blood viscometer player had originally begun its journey as DuPont’s Instrument Products Division in 1963 and was acquired in 1996 by Waters Corporation. TA Instruments reflects an acquisition fervor and has taken over several companies to expand its business. In October 2024, Waters Corporation launched the TA Instruments™ Discovery Core Rheometer, designed to be used across assurance laboratories, signifying a notable product launch.

7. Cole-Parmer Instrument Company, LLC.

Since its inception in 1955, Cole-Parmer Instrument Company, based in the U.S., has been focusing on innovation and developing products, spanning laboratory equipment, chromatography products, and test and measurement products, among others. In February 2021, the company was rebranded as Antylia Scientific™, conducting operations via its two divisions: Life Sciences and Bioprocessing.

8. IKA

IKA is renowned for its development of laboratory technology solutions. The Germany-headquartered company provides a range of viscometers that can be used in various applications, including quality control and laboratory. In January 2025, the company bagged the exclusive WirtschaftsWoche quality seal “World Market Leader - Champion” for the fifth year in a row. The award signifies that the company has made it to a select list of 520 companies of world market leaders.

9. LAMY RHEOLOGY

Based in France, LAMY RHEOLOGY, which is one of the top 10 blood viscometer companies, has created its mark with an extensive portfolio, with B-ONE PLUS and FIRST PRO PLUS being some of its products. The company was established in 1955 and shows a greater inclination toward innovation. In July 2025, the company introduced the LV SPRING and RV SPRING viscometers, which have been designed for industrial and laboratory applications.

10. Hydramotion Ltd.

K.-based Hydramotion Ltd develops viscometers catering to clientele requirements across more than 80 nations. The company’s products introduced for the pharmaceutical sector are compliant with 1935/2004/EC and have been claimed to be suitable for sterile and sanitary settings. In November 2020, the company forged a partnership with Westech Industrial. The move would bring Hydramotion’s viscometer solutions across Canada’s pharmaceutical, chemical & petrochemical, food & beverage, and other sectors.

Automated Viscometers to Gain Foot in Future Pharmaceutical Operations

Over the coming years, the debut of automation in the pharma sector is likely to drive a pivotal shift to digital and automated equipment from the usage of manual blood viscometers. This is pushing product developers to introduce advanced and tech-led equipment that could provide rapid results. On this note, to keep up with the rapidly evolving pace of technology, companies are introducing software updates to enable their clientele to garner reliable and accurate data for their measurement and analytical requirements. A significant instance is the rollout of the VROC® initium one plus software update in July 2022. This update was released by RheoSense for its VROC® initium 1++ Automated Viscometer to provide advanced communication between AutoSampler and IP cover. While industry players are deploying such steps for meeting their clientele needs and augmenting their revenues, a rise in the demand for high precision solutions is further poised to draw new opportunities for revenue generation over the ensuing years.